Breast MR Imaging for Extent of Disease Assessment in Patients with Newly Diagnosed Breast Cancer

Magnetic Resonance Imaging Clinics of North America

Volumn 21, Issue 3, 2013, Pages 519-532

  Brasic, Natasha ^a   Wisner, Dorota J ^b   Joe, Bonnie N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast MR imaging; Extent of disease; Locoregional recurrence; MR imaging breast cancer staging; MR imaging breast conservation; MR imaging lobular cancer; MR imaging tumor sizing; Preoperative MR imaging

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; EXCISION; HEALTH CARE COST; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 84881362537     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2013.04.012     Document Type: Review

References (91)

1. Anastassiades O., Iakovou E., Stavridou N., et al. Multicentricity in breast cancer. A study of 366 cases. Am J Clin Pathol 1993, 99(3):238-243.
2. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003, 98(3):468-473.
3. Fischer U., Kopka L., Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999, 213(3):881-888.
4. Hollingsworth A., Stough R., O'Dell C., et al. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008, 196:389-397.
5. Kim do Y., Moon W.K., Cho N., et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 2007, 8(1):32-39.
6. Lehman C., Isaacs C., Schnall M., et al. Cancer yield of mammography, MR and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007, 244(2):381-388.
7. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. JSurg Oncol 2005, 92(1):9-15. [discussion: 15-6].
8. Liberman L., Morris E., Dershaw D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 2003, 180:901-910.
9. Liberman L., Morris E., Kim C., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003, 180:333-341.
10. Orel S.G., Schnall M.D., Powell C.M., et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995, 196(1):115-122.
11. Pediconi F., Catalano C., Padula S., et al. Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer?. Breast Cancer Res Treat 2007, 106(1):65-74.
12. Rieber A., Merkle E., Bohm W., et al. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. JComput Assist Tomogr 1997, 21(5):773-779.
13. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004, 30(5):501-507.
14. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. JSurg Oncol 2005, 92(1):32-38.
15. Slanetz P.J., Edmister W.B., Yeh E.D., et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002, 8(3):145-148.
16. Tan J.E., Orel S.G., Schnall M.D., et al. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 1999, 22(4):414-418.
17. Tillman G.F., Orel S.G., Schnall M.D., et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. JClin Oncol 2002, 20(16):3413-3423.
18. Viehweg P., Rotter K., Laniado M., et al. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol 2004, 14(3):402-408.
19. Berg W., Gutierrez L., NessAlver M., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004, 233:830-849.
20. Boetes C., Mus R.D., Holland R., et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995, 197(3):743-747.
21. Bassett L.W., Dhaliwal S.G., Eradat J., et al. National trends and practices in breast MRI. AJR Am J Roentgenol 2008, 191(2):332-339.
22. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. NEngl J Med 2002, 347(16):1233-1241.
23. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. NEngl J Med 1995, 332(14):907-911.
24. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. NEngl J Med 2002, 347(16):1227-1232.
25. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. NEngl J Med 2007, 356(13):1295-1303.
26. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14:1725-1731.
27. Houssami N., Ciatto S., Macaskill P., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. JClin Oncol 2008, 26(19):3248-3258.
28. Hwang N., Schiller D., Crustal P., et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 2009, 16:3000-3009.
29. Solin L., Orel S., Hwang W., et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. JClin Oncol 2008, 26(3):386-391.
30. Turnbull L., Brown S., Harvey I., et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010, 375(9714):563-571.
31. Peters N., van Esser S., van den Bosch M., et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 2011, 47:879-886.
32. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106.
33. Recht A., Solin L.J. Breast-conserving surgery and radiotherapy in early-stage breast cancer: the importance of local control. Semin Radiat Oncol 2011, 21(1):3-9.
34. Bleicher R.J., Ciocca R.M., Egleston B.L., et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. JAm Coll Surg 2009, 209(2):180-187. [quiz: 294-5].
35. Brennan M.E., Houssami N., Lord S., et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. JClin Oncol 2009, 27(33):5640-5649.
36. DeMartini W.B., Hanna L., Gatsonis C., et al. Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trial. AJR Am J Roentgenol 2012, 199(3):W386-W391.
37. Hungness E.S., Safa M., Shaughnessy E.A., et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 2000, 128(4):702-707.
38. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. JClin Oncol 1990, 8(1):113-118.
39. Schouten van der Velden A.P., Schlooz-Vries M.S., Boetes C., et al. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009, 198(2):262-269.
40. Gilles R., Zafrani B., Guinebretiere J.M., et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995, 196(2):415-419.
41. Guidi A.J., Fischer L., Harris J.R., et al. Microvessel density and distribution in ductal carcinoma in situ of the breast. JNatl Cancer Inst 1994, 86(8):614-619.
42. Oshida K., Nagashima T., Ueda T., et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol 2005, 15(7):1353-1360.
43. Soderstrom C.E., Harms S.E., Copit D.S., et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996, 201(2):427-432.
44. Schouten van der Velden A.P., Boetes C., Bult P., et al. Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component. BMC Med Imaging 2009, 9:5.
45. Kuhl C.K., Schrading S., Bieling H.B., et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007, 370(9586):485-492.
46. Pilewskie M., Kennedy C., Shappell C., et al. Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol 2013, 20(5):1522-1529.
47. Kropcho L.C., Steen S.T., Chung A.P., et al. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast J 2012, 18(2):151-156.
48. Santamaría G., Velasco M., Farrús B., et al. Preoperative MRI of pure intraductal breast carcinoma-a valuable adjunct to mammography in assessing cancer extent. Breast 2008, 17(2):186-194.
49. Schouten van der Velden A.P., Boetes C., Bult P., et al. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006, 192(2):172-178.
50. Huo L., Sneige N., Hunt K.K., et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 2006, 107(8):1760-1768.
51. Rutstein L.A., Johnson R.R., Poller W.R., et al. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J 2007, 13(3):251-257.
52. Meijnen P., Oldenburg H.S., Loo C.E., et al. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg 2007, 94(8):952-956.
53. Goto M., Yuen S., Akazawa K., et al. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol 2012, 22(6):1255-1264.
54. Huang Y.T., Cheung Y.C., Lo Y.F., et al. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy. Acta Radiol 2011, 52(10):1064-1068.
55. Deurloo E.E., Sriram J.D., Teertstra H.J., et al. MRI of the breast in patients with DCIS to exclude the presence of invasive disease. Eur Radiol 2012, 22(7):1504-1511.
56. Hwang E.S., Kinkel K., Esserman L.J., et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003, 10(4):381-388.
57. Hollingsworth A.B., Stough R.G. Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast. Breast J 2012, 18(5):420-427.
58. Caramella T., Chapellier C., Ettore F., et al. Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology. Clin Imaging 2007, 31(3):155-161.
59. McGhan L.J., Wasif N., Gray R.J., et al. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best?. Ann Surg Oncol 2010, 17(Suppl 3):255-262.
60. Rodenko G.N., Harms S.E., Pruneda J.M., et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 1996, 167(6):1415-1419.
61. Rosen P.P., Fracchia A.A., Urban J.A., et al. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer 1975, 35(3):739-747.
62. Mann R., Loo C., Wobbes T., et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 2010, 119(2):415-422.
63. Houssami N., Turner R., Morrow M. Preoperative magnetic resonance imaging in breast cancer. Ann Surg 2013, 257(2):249-255.
64. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004, 292(22):2735-2742.
65. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004, 183(4):1149-1157.
66. Berg W., Zhang Z., Lehrer D., et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012, 307(13):1394-1404.
67. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56(5):979-990.
68. Lagios M.D. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer 1977, 40(4):1726-1734.
69. Vaidya J.S., Vyas J.J., Chinoy R.F., et al. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 1996, 74(5):820-824.
70. Kuhl C., Schrading S., Leutner C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. JClin Oncol 2005, 23(33):8469-8476.
71. Sardanelli F., Podo F., D'Agnolo G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007, 242(3):698-715.
72. Cole W.H., Everson T.C. Spontaneous regression of cancer: preliminary report. Ann Surg 1956, 144(3):366-383.
73. Dussan C., Zubor P., Fernandez M., et al. Spontaneous regression of a breast carcinoma: a case report. Gynecol Obstet Invest 2008, 65(3):206-211.
74. Krutchik A.N., Buzdar A.U., Blumenschein G.R., et al. Spontaneous regression of breast carcinoma. Arch Intern Med 1978, 138(11):1734-1735.
75. Rastogi P., Anderson S.J., Bear H.D., et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. JClin Oncol 2008, 26(5):778-785.
76. Marinovich M.L., Houssami N., Macaskill P., et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. JNatl Cancer Inst 2013, 105(5):321-333.
77. Vaidya J.S., Joseph D.J., Tobias J.S., et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010, 376(9735):91-102.
78. Drew P.J., Chatterjee S., Turnbull L.W., et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 1999, 6(6):599-603.
79. Harms S.E., Flamig D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993, 187(2):493-501.
80. Dorn P., Al-Hallaq H., Haq F., et al. Aprospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys 2013, 85(3):615-622.
81. Buchanan C.L., Morris E.A., Dorn P.L., et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005, 12(12):1045-1053.
82. Henry-Tillman R.S., Harms S.E., Westbrook K.C., et al. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999, 178(6):496-500.
83. Ko E.Y., Han B.K., Shin J.H., et al. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007, 8(5):382-389.
84. Lehman C., DeMartini W., Anderson B., et al. Indications for breast MRI in the patient with newly diagnosed breast cancer. JNatl Compr Canc Netw 2009, 7:193-201.
85. Obdeijn I.M., Brouwers-Kuyper E.M., Tilanus-Linthorst M.M., et al. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol 2000, 174(4):1079-1084.
86. Olson J.A., Morris E.A., Van Zee K.J., et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000, 7(6):411-415.
87. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999, 212(2):543-549.
88. Stomper P.C., Waddell B.E., Edge S.B., et al. Breast MRI in the evaluation of patients with occult primary breast carcinoma. Breast J 1999, 5(4):230-234.
89. Baron P.L., Moore M.P., Kinne D.W., et al. Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 1990, 125(2):210-214.
90. Varadarajan R., Edge S.B., Yu J., et al. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology 2006, 71(5-6):456-459.
91. Morris E., Schwarz L., Drotman M., et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 2000, 214:67-72.